Shareholding disclosure

Molecular Partners AG

Collectively declared rate

59.08%

Threshold

Crossed upwards

Timeline

Published

13.12.2014

Transaction

11.12.2014

Voting rights breakdown

Voting rights acquired59.08%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 7

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBECB000A0

Beneficial owner

Index Ventures Associates IV Limited

Declared address

Index Ventures Associates IV Limited, St. Helier, Jersey JE4 9WG

Partial exercise of the overallotment option pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). Partial exercise triggered capital increase. - Index Ventures Associates IV Limited holds its shareholding through Index Venture IV (Jersey), L.P., Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. and Yucca (Jersey) SLP; Index Ventures Associates IV Limited is the managing general partner of the direct shareholders and manages and controls the voting rights. - Essex Woodlands Health Ventures LLC holds its shareholding through Essex Woodlands Health Ventures Fund VIII L.P., Essex Woodlands Health Ventures Fund VIII-A L.P. and Essex Woodlands Health Ventures Fund VIII-B L.P.; Essex Woodlands Health Ventures LLC is the general partner of the direct shareholders, and manages and controls the voting rights. - Johnson and Johnson holds its shareholding trough Johnson & Johnson Development Corporation; Johnson & Johnson is the direct parent company of Johnson & Johnson Development Corporation. - BB Biotech Ventures GP (Guernsey) Limited holds its shareholdings through BB Biotech Ventures II L.P.; BB Biotech Ventures GP (Guernsey) Limited is the general partner of BB Biotech Ventures II L.P. and manages and controls the voting rights. - Endeavour Partners GP Limited holds part of its shareholdings through Endeavour II (Guernsey) L.P.; Endeavour Parners GP Limited is the manager of the voting rights of Endeavour II (Guernsey) L.P.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open